GB0128378D0 - Novel Compounds - Google Patents

Novel Compounds

Info

Publication number
GB0128378D0
GB0128378D0 GBGB0128378.7A GB0128378A GB0128378D0 GB 0128378 D0 GB0128378 D0 GB 0128378D0 GB 0128378 A GB0128378 A GB 0128378A GB 0128378 D0 GB0128378 D0 GB 0128378D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0128378.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB0128378.7A priority Critical patent/GB0128378D0/en
Publication of GB0128378D0 publication Critical patent/GB0128378D0/en
Priority to AT02790436T priority patent/ATE334124T1/de
Priority to AU2002365511A priority patent/AU2002365511A1/en
Priority to JP2003547388A priority patent/JP2005513036A/ja
Priority to ARP020104526A priority patent/AR037427A1/es
Priority to TW091134147A priority patent/TW200303745A/zh
Priority to PCT/EP2002/013264 priority patent/WO2003045938A1/en
Priority to EP02790436A priority patent/EP1448552B1/en
Priority to DE60213450T priority patent/DE60213450T2/de
Priority to US10/496,193 priority patent/US7045626B2/en
Priority to ES02790436T priority patent/ES2268133T3/es
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GBGB0128378.7A 2001-11-27 2001-11-27 Novel Compounds Ceased GB0128378D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB0128378.7A GB0128378D0 (en) 2001-11-27 2001-11-27 Novel Compounds
ES02790436T ES2268133T3 (es) 2001-11-27 2002-11-25 Derivados de quinolina, procedimientos de preparacion y su uso para el tratamiento de enfermedades mediadas por s-cd3.
ARP020104526A AR037427A1 (es) 2001-11-27 2002-11-25 Compuesto de quinolina, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento para prepararlo y compuestos de quinolina de utilidad como intermediarios en dicho procedimiento
AU2002365511A AU2002365511A1 (en) 2001-11-27 2002-11-25 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23
JP2003547388A JP2005513036A (ja) 2001-11-27 2002-11-25 キノリン誘導体、それらの製造方法、ならびにｓ−ＣＤ２３により媒介される障害の治療におけるそれらの使用
AT02790436T ATE334124T1 (de) 2001-11-27 2002-11-25 Chinolinderivate, herstellungsprozess und verwendung zur behandlung von krankheiten, bei den s-cd23 involviert ist
TW091134147A TW200303745A (en) 2001-11-27 2002-11-25 Novel compounds
PCT/EP2002/013264 WO2003045938A1 (en) 2001-11-27 2002-11-25 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23
EP02790436A EP1448552B1 (en) 2001-11-27 2002-11-25 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23
DE60213450T DE60213450T2 (de) 2001-11-27 2002-11-25 Chinolinderivate, herstellungsprozess und verwendung zur behandlung von krankheiten, bei den s-cd23 involviert ist
US10/496,193 US7045626B2 (en) 2001-11-27 2002-11-25 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-CD23

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0128378.7A GB0128378D0 (en) 2001-11-27 2001-11-27 Novel Compounds

Publications (1)

Publication Number Publication Date
GB0128378D0 true GB0128378D0 (en) 2002-01-16

Family

ID=9926525

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0128378.7A Ceased GB0128378D0 (en) 2001-11-27 2001-11-27 Novel Compounds

Country Status (11)

Country Link
US (1) US7045626B2 (enExample)
EP (1) EP1448552B1 (enExample)
JP (1) JP2005513036A (enExample)
AR (1) AR037427A1 (enExample)
AT (1) ATE334124T1 (enExample)
AU (1) AU2002365511A1 (enExample)
DE (1) DE60213450T2 (enExample)
ES (1) ES2268133T3 (enExample)
GB (1) GB0128378D0 (enExample)
TW (1) TW200303745A (enExample)
WO (1) WO2003045938A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4505859B2 (ja) 2003-08-08 2010-07-21 味の素株式会社 ナテグリニド含有製剤
AU2012338581B2 (en) 2011-11-18 2016-12-08 Nxera Pharma Uk Limited Muscarinic M1 receptor agonists
JP6478923B2 (ja) 2013-02-07 2019-03-06 ヘプタレス セラピューティクス リミテッドＨｅｐｔａｒｅｓ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ ムスカリンｍ４受容体アゴニストとしてのピペリジン−１−イル及びアゼピン−１−イルカルボキシレート
GB201404922D0 (en) 2014-03-19 2014-04-30 Heptares Therapeutics Ltd Pharmaceutical compounds
GB201513743D0 (en) 2015-08-03 2015-09-16 Heptares Therapeutics Ltd Muscarinic agonists
GB201519352D0 (en) 2015-11-02 2015-12-16 Heptares Therapeutics Ltd Pharmaceutical compounds
GB201617454D0 (en) 2016-10-14 2016-11-30 Heptares Therapeutics Limited Pharmaceutical compounds
GB201810239D0 (en) 2018-06-22 2018-08-08 Heptares Therapeutics Ltd Pharmaceutical compounds
GB201819960D0 (en) 2018-12-07 2019-01-23 Heptares Therapeutics Ltd Pharmaceutical compounds
GB201819961D0 (en) 2018-12-07 2019-01-23 Heptares Therapeutics Ltd Pharmaceutical compounds
GB202020191D0 (en) 2020-12-18 2021-02-03 Heptares Therapeutics Ltd Pharmaceutical compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1001930T3 (da) * 1997-07-31 2003-03-24 Abbott Lab N-hydroxyformamidderivater som inhibitorer af matrix-metalloproteinaser
HUP0100597A3 (en) 1998-01-30 2001-12-28 Darwin Discovery Ltd Cambridge Hydroxamic and carboxylic acid derivatives

Also Published As

Publication number Publication date
AU2002365511A1 (en) 2003-06-10
US20050085505A1 (en) 2005-04-21
EP1448552A1 (en) 2004-08-25
ATE334124T1 (de) 2006-08-15
JP2005513036A (ja) 2005-05-12
DE60213450D1 (de) 2006-09-07
US7045626B2 (en) 2006-05-16
ES2268133T3 (es) 2007-03-16
WO2003045938A1 (en) 2003-06-05
TW200303745A (en) 2003-09-16
EP1448552B1 (en) 2006-07-26
AR037427A1 (es) 2004-11-10
DE60213450T2 (de) 2007-09-20

Similar Documents

Publication Publication Date Title
GB0105895D0 (en) Novel compounds
GB0106586D0 (en) Novel compounds
GB0128378D0 (en) Novel Compounds
GB0104259D0 (en) Novel compounds
GB0102713D0 (en) Novel compounds
GB0102470D0 (en) Novel compounds
GB0103866D0 (en) Novel compounds
GB0102714D0 (en) Novel compounds
GB0105095D0 (en) Novel compounds
GB0100186D0 (en) Novel compounds
GB0100187D0 (en) Novel compounds
GB0101334D0 (en) Novel compounds
GB0101437D0 (en) Novel Compounds
GB0102469D0 (en) Novel compounds
GB0100184D0 (en) Novel compounds
GB0106155D0 (en) Novel Compounds
GB0102571D0 (en) Novel Compounds
GB0102575D0 (en) Novel Compounds
GB0102576D0 (en) Novel compounds
GB0102577D0 (en) Novel Compounds
GB0102578D0 (en) Novel Compounds
GB0102711D0 (en) Novel compounds
GB0100182D0 (en) Novel compounds
GB0105634D0 (en) Novel compounds
GB0103175D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)